Skip to content

Effectiveness of Group and Individual Training in EFT for Patients in Remission From Melanoma

Effectiveness of Group and Individual Training in Emotional Freedom Techniques for Patients in Remission From Melanoma

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05421988
Enrollment
56
Registered
2022-06-16
Start date
2022-10-20
Completion date
2025-07-20
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma (Skin)

Brief summary

Serious medical diagnosis frequently induce fear focused on specific anticipations or generalized anxiety, along with uncertainty, insecurity, and disorientation. Other emotions such as anger, depression, hopelessness, shame, or grief may also become involved following a serious diagnosis. The adverse impact of stress on health and immune function is well-established, as well as its link to depression and anxiety. Emotional Freedom Techniques (EFT) has demonstrated efficacy in treating anxiety, depression, and PTSD. This study tests its effectiveness in reducing negative emotional symptoms in general, and fear of recurrence in particular, among individuals previously diagnosed with melanoma and currently in remission.

Detailed description

Serious medical diagnosis frequently induce fear focused on specific anticipations or generalized anxiety, along with uncertainty, insecurity, and disorientation. Other emotions such as anger, depression, hopelessness, shame, or grief may also become involved following a serious diagnosis. The adverse impact of stress on health and immune function is well-established, as well as its link to depression and anxiety. Emotional Freedom Techniques (EFT) has demonstrated efficacy in treating anxiety, depression, and PTSD. This study tests its effectiveness in reducing negative emotional symptoms in general, and fear of recurrence in particular, among individuals previously diagnosed with melanoma and currently in remission. Specifically, the study aims: 1. To assess the effect of instruction and practice of EFT on illness perception, fear of cancer recurrence, and wellbeing. 2. To assess whether the social support provided by EFT instruction in a group setting makes this efficient mode of implementation non-inferior or even beneficial in comparison to personal instruction. 3. To describe the emotions related to life events reported by patients in connection with the appearance and location of melanoma.

Interventions

EFT is an efficacious method demonstrated in over 100 clinical trials. It combines cognitive and exposure techniques with acupressure, in the form of fingertip percussion on acupuncture meridian points.

Sponsors

Soul Medicine Institute
Lead SponsorOTHER
Tel Aviv University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants in the two treatment arms, and data analysts, will be blind to group assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Melanoma diagnosis over six months prior to the study; confirmed by clinical, dermoscopic examination and pathology results

Exclusion criteria

* In active treatment for melanoma * schizophrenia * epilepsy * other malignant disease

Design outcomes

Primary

MeasureTime frameDescription
Illness perceptionPre intervention, post 4 week intervention, and 3 month follow-upChange in score on Revised Illness Perception Questionnaire (IPQ-R)
Perception of recurrencePre intervention, post 4 week intervention, and 3 month follow-upChange of perceived recurrence risk on a Likert scale

Secondary

MeasureTime frameDescription
Other physical symptomsPre intervention, post 4 week intervention, and 3 month follow-upChange in patient's self-report of somatization, pain, and other symptoms on a Likert scale
DepressionPre intervention, post 4 week intervention, and 3 month follow-upChange in depressive symptoms on the Positive and Negative Affect Schedule (PANAS)
AnxietyPre intervention, post 4 week intervention, and 3 month follow-upChange in anxiety symptoms on the Positive and Negative Affect Schedule (PANAS)
Patient's self-report of quality of lifePre intervention, post 4 week intervention, and 3 month follow-upChange in quality of life scores on the Quality of Life Scale (QOLS)
WellbeingPre intervention, post 4 week intervention, and 3 month follow-upChange in score on The Well-being Numerical Rating Scales (WB-NRSs).

Countries

Israel

Contacts

STUDY_DIRECTORYael Benyamini, PhD

Tel Aviv University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026